The U.K.'s Medicines and Healthcare products Regulatory Agency is seeking consultation with medical-device companies in regard to a draft guidance on reporting adverse events related to neurostimulators. The consultation on the guidance, which intends to streamline the application and enforcement of the medical devices directive 93/42/EEC, is set to close at the end of September.

Related Summaries